• edje
    keep an eye on VVUS. FDA adcom meeting 2/22 on their potentially blockbuster obesity drug. also have an ED therapy in the pipeline. DYODD
    2/16/12
    Reply (10)
    • FortSumter: what the heck just happened....dropped off a cliff?
      2/16/12
    • edje: apparently comments made by an FDA member about cardiovascular risks of the drug
      2/16/12
    • phemale60: thought cardio was settled with good results?!! suspicious rumor to bring price down?
      2/17/12
    • phemale60: watched VVUS wild swings in real time; looked like stop loss action
      2/17/12
    • edje: people are speculating it was some old bankster tricks, check out the yahoo message board community for VVUS
      2/17/12
    • regnilsek: Is this acceptable for FDA members to attend these conferences and discuss these matters informally?
      2/17/12
    • phemale60: I'm wondering the same thing. Seems unethical. Good article in NYTimes: http://nyti.ms/wMlHzq Not sure if the link I pasted works.
      2/17/12
    • phemale60: It works; and ABC World News Tonight did a piece on Qnexa which was pretty positive. http://abcn.ws/yx30JH
      2/18/12
    • edje: congrats phemale
      2/22/12
    • phemale60: Thanks --- almost sold some this morn but was frozen. Thank goodness!!!
      2/22/12